CARA LYNN CAHILL NP
Prescription History 1659611713
Nurse Practitioner - Adult Health in Wilton, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CARA LYNN CAHILL NP, an active Adult Health specialist practicing in Wilton, NY. Our medical registry currently tracks 44 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,827 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 155 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Levothyroxine Sodium | 155 | $20.40 | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 155 Medicare prescriptions for Levothyroxine Sodium, about 1.2 times the volume of the typical New York prescriber of this medication (129). Medicare paid an average of $20.40 per fill, versus $18.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 358.6 30-Day Fills standardized to 30-day supplies 10,658 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 125 | $11.77 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 125 Medicare prescriptions for Metformin Hcl Er, about 2.4 times the volume of the typical New York prescriber of this medication (53). Medicare paid an average of $11.77 per fill, versus $11.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 317 30-Day Fills standardized to 30-day supplies 9,336 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 117 | $1,475.01 | ▲ More than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 117 Medicare prescriptions for Novolog Flexpen, about 3.3 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $1,475.01 per fill, versus $851.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 229.3 30-Day Fills standardized to 30-day supplies 6,762 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 108 | $1,621.29 | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 108 Medicare prescriptions for Trulicity, about 2.2 times the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $1,621.29 per fill, versus $1,383.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 182.2 30-Day Fills standardized to 30-day supplies 5,340 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 107 | $833.99 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 107 Medicare prescriptions for Lantus Solostar, about 3 times the volume of the typical New York prescriber of this medication (36). Medicare paid an average of $833.99 per fill, versus $582.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 223.8 30-Day Fills standardized to 30-day supplies 6,709 Days of Medication total across all patients in 2023 | |||
| OzempicSemaglutide | 93 | $1,908.37 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 93 Medicare prescriptions for Ozempic, about 2 times the volume of the typical New York prescriber of this medication (47). Medicare paid an average of $1,908.37 per fill, versus $1,419.80 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 181.5 30-Day Fills standardized to 30-day supplies 5,372 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 74 | $511.87 | ▲ More than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 74 Medicare prescriptions for Basaglar Kwikpen U-100, about 2.1 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $511.87 per fill, versus $373.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 145.3 30-Day Fills standardized to 30-day supplies 4,313 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-200Insulin Degludec | 71 | $964.08▼ below NY avg | ▲ More than typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 71 Medicare prescriptions for Tresiba Flextouch U-200, about 2.4 times the volume of the typical New York prescriber of this medication (30). Medicare paid an average of $964.08 per fill, versus $1,159.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 96.2 30-Day Fills standardized to 30-day supplies 2,624 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 66 | $14.92 | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 66 Medicare prescriptions for Metformin Hcl, about 69% of the volume of the typical New York prescriber of this medication (96). Medicare paid an average of $14.92 per fill, versus $8.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 143.3 30-Day Fills standardized to 30-day supplies 4,300 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 60 | $109.33 | ▲ More than typical |
In 2023, this provider wrote 60 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 2.6 times the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $109.33 per fill, versus $80.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 129.4 30-Day Fills standardized to 30-day supplies 3,812 Days of Medication total across all patients in 2023 | |||
| Glipizide ErGlipizide | 57 | $22.74 | ▲ More than typical |
About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 57 Medicare prescriptions for Glipizide Er, about 1.6 times the volume of the typical New York prescriber of this medication (36). Medicare paid an average of $22.74 per fill, versus $17.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 144 30-Day Fills standardized to 30-day supplies 4,320 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 55 | $1,451.17 | ≈ Typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 55 Medicare prescriptions for Jardiance, about 1.2 times the volume of the typical New York prescriber of this medication (47). Medicare paid an average of $1,451.17 per fill, versus $1,077.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 135 30-Day Fills standardized to 30-day supplies 4,040 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 53 | $13.72 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 53 Medicare prescriptions for Atorvastatin Calcium, about a third of the volume of the typical New York prescriber of this medication (180). Medicare paid an average of $13.72 per fill, versus $13.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 111 30-Day Fills standardized to 30-day supplies 3,330 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 48 | $11.30▼ below NY avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 48 Medicare prescriptions for Gabapentin, about 62% of the volume of the typical New York prescriber of this medication (78). Medicare paid an average of $11.30 per fill, versus $17.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,280 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 40 | $1,682.31 | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 40 Medicare prescriptions for Humalog Kwikpen U-100, about 1.4 times the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $1,682.31 per fill, versus $931.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 104.4 30-Day Fills standardized to 30-day supplies 3,128 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 38 | $123.86 | ≈ Typical |
In 2023, this provider wrote 38 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 1.2 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $123.86 per fill, versus $93.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.3 30-Day Fills standardized to 30-day supplies 3,190 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 36 | $107.17 | ▲ More than typical |
In 2023, this provider wrote 36 Medicare prescriptions for Ultra-Fine Short Pen Needle, about 1.8 times the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $107.17 per fill, versus $81.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 75.1 30-Day Fills standardized to 30-day supplies 2,098 Days of Medication total across all patients in 2023 | |||
| TradjentaLinagliptin | 33 | $1,145.65 | ≈ Typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2023, this provider wrote 33 Medicare prescriptions for Tradjenta, about the same volume as the typical New York prescriber of this medication (33). Medicare paid an average of $1,145.65 per fill, versus $832.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69 30-Day Fills standardized to 30-day supplies 2,070 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 33 | $1,041.67 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 33 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $1,041.67 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,041.67 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 85.2 30-Day Fills standardized to 30-day supplies 2,556 Days of Medication total across all patients in 2023 | |||
| PentipsPen Needle, Diabetic | 29 | $15.16▼ below NY avg | ▲ More than typical |
In 2023, this provider wrote 29 Medicare prescriptions for Pentips, about 1.3 times the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $15.16 per fill, versus $18.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 40.7 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| Victoza 3-PakLiraglutide | 29 | $1,421.30▼ below NY avg | ▲ More than typical |
About Victoza 3-Pak: This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Show more ▾ It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite. An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN. In 2023, this provider wrote 29 Medicare prescriptions for Victoza 3-Pak, about 1.3 times the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $1,421.30 per fill, versus $1,712.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 37.5 30-Day Fills standardized to 30-day supplies 1,125 Days of Medication total across all patients in 2023 | |||
| Glimepiride | 29 | $12.79 | ▼ Less than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family. In 2023, this provider wrote 29 Medicare prescriptions for Glimepiride, about 66% of the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $12.79 per fill, versus $12.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 76.6 30-Day Fills standardized to 30-day supplies 2,293 Days of Medication total across all patients in 2023 | |||
| JanuviaSitagliptin Phosphate | 26 | $1,164.57 | ▼ Less than typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2023, this provider wrote 26 Medicare prescriptions for Januvia, about half the volume of the typical New York prescriber of this medication (45). Medicare paid an average of $1,164.57 per fill, versus $952.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-100Insulin Degludec | 25 | $824.83 | ≈ Typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 25 Medicare prescriptions for Tresiba Flextouch U-100, about 86% of the volume of the typical New York prescriber of this medication (29). Medicare paid an average of $824.83 per fill, versus $678.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63.3 30-Day Fills standardized to 30-day supplies 1,891 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 23 | $8.51 | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 23 Medicare prescriptions for Lisinopril, about a quarter of the volume of the typical New York prescriber of this medication (91). Medicare paid an average of $8.51 per fill, versus $7.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53 30-Day Fills standardized to 30-day supplies 1,590 Days of Medication total across all patients in 2023 | |||
| Glipizide | 23 | $6.71▼ below NY avg | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 23 Medicare prescriptions for Glipizide, about 68% of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $6.71 per fill, versus $8.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 55 30-Day Fills standardized to 30-day supplies 1,622 Days of Medication total across all patients in 2023 | |||
| HumalogInsulin Lispro | 21 | $1,142.02 | ≈ Typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 21 Medicare prescriptions for Humalog, about 88% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $1,142.02 per fill, versus $786.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.8 30-Day Fills standardized to 30-day supplies 1,261 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 20 | $101.08 | ▼ Less than typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 20 Medicare prescriptions for Synthroid, about a third of the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $101.08 per fill, versus $73.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2023 | |||
| NovologInsulin Aspart | 20 | $1,840.69 | ≈ Typical |
About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 20 Medicare prescriptions for Novolog, about 80% of the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,840.69 per fill, versus $1,084.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.5 30-Day Fills standardized to 30-day supplies 1,508 Days of Medication total across all patients in 2023 | |||
| Insulin Aspart | 17 | $483.22 | ≈ Typical |
About Insulin Aspart: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 17 Medicare prescriptions for Insulin Aspart, about the same volume as the typical New York prescriber of this medication (15). Medicare paid an average of $483.22 per fill, versus $271.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.4 30-Day Fills standardized to 30-day supplies 1,182 Days of Medication total across all patients in 2023 | |||
| Pravastatin Sodium | 17 | $16.60▼ below NY avg | ▼ Less than typical |
About Pravastatin Sodium: Pravastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES). In 2023, this provider wrote 17 Medicare prescriptions for Pravastatin Sodium, about a third of the volume of the typical New York prescriber of this medication (45). Medicare paid an average of $16.60 per fill, versus $17.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 17 | $100.43 | ≈ Typical |
In 2023, this provider wrote 17 Medicare prescriptions for Droplet Pen Needle, about 89% of the volume of the typical New York prescriber of this medication (19). Medicare paid an average of $100.43 per fill, versus $66.65 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52.3 30-Day Fills standardized to 30-day supplies 1,570 Days of Medication total across all patients in 2023 | |||
| Unifine Pentips PlusPen Needle, Diabetic | 17 | $43.41 | ≈ Typical |
In 2023, this provider wrote 17 Medicare prescriptions for Unifine Pentips Plus, about the same volume as the typical New York prescriber of this medication (18). Medicare paid an average of $43.41 per fill, versus $36.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52.1 30-Day Fills standardized to 30-day supplies 1,563 Days of Medication total across all patients in 2023 | |||
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,389.48 | ▼ Less than typical |
About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 16 Medicare prescriptions for Toujeo Max Solostar, about 64% of the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,389.48 per fill, versus $1,267.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.6 30-Day Fills standardized to 30-day supplies 588 Days of Medication total across all patients in 2023 | |||
| Ulticare Pen NeedlePen Needle, Diabetic | 16 | $97.87 | ≈ Typical |
In 2023, this provider wrote 16 Medicare prescriptions for Ulticare Pen Needle, about the same volume as the typical New York prescriber of this medication (17). Medicare paid an average of $97.87 per fill, versus $69.35 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 459 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 16 | $101.28 | ▼ Less than typical |
In 2023, this provider wrote 16 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 67% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $101.28 per fill, versus $77.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.5 30-Day Fills standardized to 30-day supplies 880 Days of Medication total across all patients in 2023 | |||
| Omnipod 5 G6 Pods (Gen 5)Insulin Pump Cart,automated,bt | 15 | $1,132.03▼ below NY avg | ≈ Typical |
In 2023, this provider wrote 15 Medicare prescriptions for Omnipod 5 G6 Pods (Gen 5), about the same volume as the typical New York prescriber of this medication (16). Medicare paid an average of $1,132.03 per fill, versus $1,438.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26.5 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| Rosuvastatin Calcium | 14 | $32.27 | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2023, this provider wrote 14 Medicare prescriptions for Rosuvastatin Calcium, about 14% of the volume of the typical New York prescriber of this medication (101). Medicare paid an average of $32.27 per fill, versus $29.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2023 | |||
| Pioglitazone Hcl | 12 | $19.14 | ▼ Less than typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. In 2023, this provider wrote 12 Medicare prescriptions for Pioglitazone Hcl, about a third of the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $19.14 per fill, versus $15.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| Easy Touch Pen NeedlePen Needle, Diabetic | 12 | $54.19 | ▼ Less than typical |
In 2023, this provider wrote 12 Medicare prescriptions for Easy Touch Pen Needle, about 71% of the volume of the typical New York prescriber of this medication (17). Medicare paid an average of $54.19 per fill, versus $52.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.7 30-Day Fills standardized to 30-day supplies 270 Days of Medication total across all patients in 2023 | |||
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 11 | $1,009.55▼ below NY avg | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Omnipod Dash Pods (Gen 4), about half the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,009.55 per fill, versus $1,256.54 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| Gvoke Hypopen 2-PackGlucagon | 11 | $623.38▼ below NY avg | ▼ Less than typical |
About Gvoke Hypopen 2-Pack: This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Show more ▾ It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help. Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms. In 2023, this provider wrote 11 Medicare prescriptions for Gvoke Hypopen 2-Pack, about half the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $623.38 per fill, versus $665.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 130 Days of Medication total across all patients in 2023 | |||
| Insulin Aspart FlexpenInsulin Aspart | 11 | $496.55 | ▼ Less than typical |
About Insulin Aspart Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 11 Medicare prescriptions for Insulin Aspart Flexpen, about 61% of the volume of the typical New York prescriber of this medication (18). Medicare paid an average of $496.55 per fill, versus $204.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.4 30-Day Fills standardized to 30-day supplies 581 Days of Medication total across all patients in 2023 | |||
| Armour ThyroidThyroid,pork | 11 | $88.24 | ▼ Less than typical |
About Armour Thyroid: Thyroid hormone is used to treat underactive thyroid (hypothyroidism). Show more ▾ It is a natural product made from animal thyroid glands (usually a pig's). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as certain types of goiters, thyroid cancer) and also to test for thyroid function. This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. Older adults should discuss the risks and benefits of this medication with their doctor or pharmacist. In 2023, this provider wrote 11 Medicare prescriptions for Armour Thyroid, about half the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $88.24 per fill, versus $68.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for CARA LYNN CAHILL NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Adult Health prescribing approach at this Wilton, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
